Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mike Mensinger currently holds 180,040 shares of Beta Bionics, Inc. (BBNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mike Mensinger has been a net seller of BBNX stock. They have purchased $0 and sold $203.7K worth of shares.
Mike Mensinger's most recent insider trade was on Sep 2, 2026, when they sold 4,375 shares at $19.11 per share.
Mike Mensinger serves as Executive at Beta Bionics, Inc. (BBNX). They have executed 7 insider transactions totaling $203.7K over their tenure at the company.
Mike Mensinger holds the position of Executive at Beta Bionics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Mike Mensinger has shown a selling trading pattern, with $0 in total purchases and $203.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mike Mensinger was on Sep 2, 2026, when they sold $83.6K worth of BBNX shares. This transaction involved 4,375 shares at $19.11 per share.
Mike Mensinger currently owns 180,040 shares of Beta Bionics, Inc. (BBNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mike Mensinger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mike Mensinger has 7 Form 4 filings on record as an insider at Beta Bionics, Inc..
Set alerts for Mike Mensinger and 40,000+ other insiders.